Related Experiment Video
Updated: Jan 22, 2026

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
Published on: March 8, 2024
Single-dose Intravenous Ondansetron in Children with Gastroenteritis: A Randomized Controlled Trial
Nguyen Ngoc Rang1, Ton Quang Chanh2, Pham The My2
1Department of Pediatrics, Can Tho University of Medicine and Pharmacy, Vietnam. Correspondence to: Dr Nguyen Ngoc Rang, Pediatric Department of Can Tho University of Medicine and Pharmacy, 179 Nguyen Van Cu, Can Tho, Vietnam. nguyenngocrang@gmail.com.
Insights
Ondansetron effectively stops vomiting in children with gastroenteritis, reducing the need for intravenous (IV) rehydration. This study shows ondansetron is a beneficial treatment for pediatric vomiting associated with gastroenteritis.
Area of Science:
- Pediatric Gastroenterology
- Clinical Pharmacology
Background:
- Gastroenteritis is a common cause of vomiting in children.
- Intravenous (IV) rehydration is often necessary for severe vomiting, increasing healthcare costs and patient discomfort.
Purpose of the Study:
- To evaluate the efficacy of ondansetron in treating vomiting in children with gastroenteritis.
- To determine if ondansetron reduces the requirement for IV rehydration.
Main Methods:
- A double-blind, placebo-controlled, randomized trial was conducted.
- 61 inpatient children (11-60 months) with gastroenteritis and vomiting received either IV ondansetron (0.2 mg/kg) or placebo.
- Outcomes included cessation of vomiting, need for IV rehydration, oral intake, diarrhea duration, and hospital stay.
Main Results:
- Complete cessation of vomiting occurred in 73% of the ondansetron group versus 23% in the placebo group (P<0.001).
- Only 10% of ondansetron recipients required IV rehydration compared to 39% in the placebo group (P=0.009).
- Oral rehydration solution intake was significantly greater in the ondansetron group.
Conclusions:
- Ondansetron is effective in achieving cessation of vomiting in hospitalized children with gastroenteritis.
- Ondansetron significantly reduces the need for IV rehydration in this patient population.
- The drug did not affect the duration of diarrhea or hospital stay.
Objective:
To evaluate the efficacy of ondansetron for the treatment of vomiting and thus reducing the need for intravenous (IV) rehydration in children with gastroenteritis.
Design:
Double-blind, placebo-controlled, randomized trial.
Setting:
Pediatric ward of An Giang General Hospital, South Vietnam, between December 2013 and June 2014.
Participants:
61 inpatient children (age 11-60 mo) suffering from gastroenteritis with vomiting. Exclusion criteria were: underlying chronic conditions, immunodeficiency, malnutrition or history of allergy to ondansetron.
Intervention:
Single bolus of IV ondansetron at a dose of 0.2 mg/kg or placebo.
Outcome Measures:
Proportion of patients who needed IV rehydration, proportion of patients with cessation of vomiting, amount of oral rehydration solution intake, duration of diarrhea and the length of hospital stay.
Results:
After drug administration, 22 (73%) of the 30 patients in the ondansetron group had complete cessation of vomiting compared with 7 (23%) of the 31 patients in the placebo group (RR 0.32; 95% CI 0.16 to 0.63, P<0.001). 3 (10%) patients in the ondansetron group required IV rehydration as compared with 12 (39%) in the placebo group (RR 0.51; 95% CI 0.33 to 0.79, P=0.009). The median amount of oral rehydration solution intake in 24 hours was significantly greater in the ondansetron group (450 mL vs 350 mL, P=0.019).The duration of diarrhea and the length of hospital stay were not different between the two groups.
Conclusions:
In hospitalized children having gastro-enteritis associated with emesis, ondansetron is effective in the cessation of episodes of vomiting and in lowering the rates of IV rehydration, without reducing the duration of diarrhea and hospital stay.
More Related Videos
Related Concept Videos
Drug Dosing: Infants and Children
Bioavailability Study Design: Single Versus Multiple Dose Studies
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Trial and Error and Algorithm
Random Error

